ArticleInternational journal of women's health2026
Rising Ovarian Cancer Burden in Africa, 2009-2023: Epidemiological Change, Age-Specific Patterns, COVID-19-Related Deviations, and Future Forecasts.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian cancer is an important cause of cancer morbidity and mortality among women, but continent-wide evidence from Africa remains limited. We used Global Burden of Disease (GBD) 2023 estimates to assess ovarian cancer burden among African females from 2009 to 2023. Methods: We conducted a population-level ecological analysis of GBD 2023 estimates for 54 African countries. We assessed incidence, prevalence, deaths, disability-adjusted life-years (DALYs), age-standardised rates (ASRs), temporal trends, Socio-demographic Index (SDI) correlations, Das Gupta decomposition, age-specific patterns, COVID-19-period deviations, and exploratory autoregressive integrated moving average (ARIMA) projections to 2040. Results: Between 2009 and 2023, incident cases increased from 14,582 to 40,884, deaths from 9,099 to 24,123, and DALYs from 338,844 to 919,069. Nigeria had the largest absolute burden in 2023, whereas the highest ASRs were concentrated mainly in eastern and central sub-Saharan Africa. SDI was not significantly associated with 2023 ASRs, and inverse associations between SDI and temporal increases were weak and nonsignificant. Decomposition attributed the largest share of the increase in absolute burden to the rate-related component, with additional contributions from population growth and ageing. Age-specific incidence and mortality generally increased with age and peaked in older age groups. During 2020-2023, observed burden exceeded counterfactual estimates overall after a below-expected pattern in 2020. Exploratory ARIMA projections suggested possible further ASR increases through 2040, with widening prediction intervals. Conclusion: GBD 2023 estimates indicate a rising ovarian cancer burden among women in Africa, with substantial geographical and age-specific heterogeneity. Strengthening cancer surveillance, diagnosis, pathology, surgery, and access to systemic treatment is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.